AI assistant
Sending…
Hansa Biopharma — Major Shareholding Notification 2016
Mar 8, 2016
3057_iss_2016-03-08_b1a1813d-798c-4c30-94b8-362860526e04.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Gladiator
Instrument
| Instrument | aktie SE0002148817 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,490,000 | |
| Voting rights | 1,490,000 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 08/03/2016 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 2,490,000 | |
| Directly held voting rights | 2,490,000 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 7.6823 % | |
| Directly held voting rights | 7.6823 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 7.6823 % | 2,490,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 7.6823 % | 2,490,000 |
| Group total holdings | ||
| Voting rights 2,490,000 Percentage of voting rights 7.6823 |
||
| Published 08/03/2016 13:17 |
||
| Contact | ||
| Name Max Mitteregger |
||
| Phone 0854504841 |
Email [email protected] | |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Hansa Biopharma
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Capital/Financing Update
2026
May 19
Capital/Financing Update
2026
May 19
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Interim / Quarterly Report
2026
Apr 23
Interim / Quarterly Report
2026
Apr 23